These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2498924)

  • 1. The hyperalgesic effect of naloxone is attenuated in streptozotocin-diabetic mice.
    Ramabadran K; Bansinath M; Turndorf H; Puig MM
    Psychopharmacology (Berl); 1989; 97(2):169-74. PubMed ID: 2498924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of yohimbine on nociceptive threshold in normoglycemic and streptozotocin-treated hyperglycemic mice.
    Bansinath M; Ramabadran K; Turndorf H; Puig MM
    Pharmacol Biochem Behav; 1989 Jun; 33(2):459-63. PubMed ID: 2813484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kappa-opioid receptor-mediated thermonociceptive mechanisms in streptozotocin diabetes.
    Bansinath M; Ramabadran K; Turndorf H; Puig MM
    Physiol Behav; 1991 Apr; 49(4):729-33. PubMed ID: 1652774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible involvement of cholinergic and opioid receptor mechanisms in fluoxetine mediated antinociception response in streptozotocin-induced diabetic mice.
    Anjaneyulu M; Chopra K
    Eur J Pharmacol; 2006 May; 538(1-3):80-4. PubMed ID: 16650402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paradoxical analgesia produced by naloxone in diabetic mice is attributable to supersensitivity of delta-opioid receptors.
    Kamei J; Kawashima N; Kasuya Y
    Brain Res; 1992 Oct; 592(1-2):101-5. PubMed ID: 1450902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinin B1 receptor antagonists inhibit diabetes-induced hyperalgesia in mice.
    Gabra BH; Sirois P
    Neuropeptides; 2003 Feb; 37(1):36-44. PubMed ID: 12637034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of opioid receptors in diabetes and hyperglycemia-induced changes in pain threshold in the rat.
    Akunne HC; Soliman KF
    Psychopharmacology (Berl); 1987; 93(2):167-72. PubMed ID: 2827214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delayed postoperative latent pain sensitization revealed by the systemic administration of opioid antagonists in mice.
    Campillo A; Cabañero D; Romero A; García-Nogales P; Puig MM
    Eur J Pharmacol; 2011 Apr; 657(1-3):89-96. PubMed ID: 21300053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blockade of mu-opioid receptors reveals the hyperalgesic effect of orphanin FQ/nociceptin in the rat hot plate test.
    Lutfy K; Maidment NT
    Br J Pharmacol; 2000 Dec; 131(8):1684-8. PubMed ID: 11139447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperalgesia in non-obese diabetic (NOD) mice: a role for the inducible bradykinin B1 receptor.
    Gabra BH; Sirois P
    Eur J Pharmacol; 2005 May; 514(1):61-7. PubMed ID: 15878325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beneficial effect of chronic treatment with the selective bradykinin B1 receptor antagonists, R-715 and R-954, in attenuating streptozotocin-diabetic thermal hyperalgesia in mice.
    Gabra BH; Sirois P
    Peptides; 2003 Aug; 24(8):1131-9. PubMed ID: 14612183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spinal orexin-1 receptors mediate anti-hyperalgesic effects of intrathecally-administered orexins in diabetic neuropathic pain model rats.
    Kajiyama S; Kawamoto M; Shiraishi S; Gaus S; Matsunaga A; Suyama H; Yuge O
    Brain Res; 2005 May; 1044(1):76-86. PubMed ID: 15862792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation of an opioid-mediated antinociceptive mechanism in transgenic mice over-expressing substance P in the spinal cord.
    McLeod AL; Ritchie J; Cuello AC; Julien JP; Henry JL; Ribeiro-da-Silva A
    Neuroscience; 2000; 96(4):785-9. PubMed ID: 10727796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of bradykinin B(1) receptors in diabetes-induced hyperalgesia in streptozotocin-treated mice.
    Gabra BH; Sirois P
    Eur J Pharmacol; 2002 Dec; 457(2-3):115-24. PubMed ID: 12464357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperalgesia induced by naloxone follows diurnal rhythm in responsivity to painful stimuli.
    Frederickson RC; Burgis V; Edwards JD
    Science; 1977 Nov; 198(4318):756-8. PubMed ID: 561998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nociception, antinociceptive potency of morphine in streptozotocin induced diabetic rats.
    Mahajan AS; Chakrabarty K; Mishra TK; Chakrabarty AS
    Indian J Physiol Pharmacol; 1997 Oct; 41(4):416-20. PubMed ID: 10235666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Naloxone rapidly evokes endogenous kappa opioid receptor-mediated hyperalgesia in naïve mice pretreated briefly with GM1 ganglioside or in chronic morphine-dependent mice.
    Crain SM; Shen KF
    Brain Res; 2007 Sep; 1167():31-41. PubMed ID: 17692296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tail immersion test for the evaluation of a nociceptive reaction in mice. Methodological considerations.
    Ramabadran K; Bansinath M; Turndorf H; Puig MM
    J Pharmacol Methods; 1989 Mar; 21(1):21-31. PubMed ID: 2704245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mouse-killing in rats induces a naloxone-blockable increase in nociceptive threshold.
    Kromer W; Dum JE
    Eur J Pharmacol; 1980 May; 63(2-3):195-8. PubMed ID: 6247166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological characterization of different fractions of Calotropis procera (Asclepiadaceae) in streptozotocin induced experimental model of diabetic neuropathy.
    Yadav SK; Nagori BP; Desai PK
    J Ethnopharmacol; 2014 Mar; 152(2):349-57. PubMed ID: 24486599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.